[Clinical Significance of Inflammatory Markers in Recombinant Human-Soluble Thrombomodulin Therapy for DIC in Solid Tumors].

Yabumoto, Akimichi; Kashiwagi, Shinichiro; Asano, Yuka; Kawano, Yuko; Kouhashi, Rika; Ishihara, Sae; Goto, Wataru; Tauchi, Yukie; Morisaki, Tamami; Noda, Satoru; Takashima, Tsutomu; Hirakawa, Kosei; Ohira, Masaichi

Yabumoto, Akimichi; Kashiwagi, Shinichiro; Asano, Yuka; Kawano, Yuko; Kouhashi, Rika; Ishihara, Sae; Goto, Wataru; Tauchi, Yukie; Morisaki, Tamami; Noda, Satoru; Takashima, Tsutomu; Hirakawa, Kosei; Ohira, Masaichi.

Afiliación

Yabumoto A; Dept. of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine.

Gan To Kagaku Ryoho ; 47(13): 1939-1941, 2020 Dec.

Article en Ja | MEDLINE | ID: mdl-33468759

Asunto(s)

Neoplasias; Trombomodulina; Humanos; Linfocitos; Neoplasias/tratamiento farmacológico; Neutrófilos; Estudios Retrospectivos

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombomodulina / Neoplasias Tipo de estudio: Observational_studies Límite: Humans Idioma: Ja Revista: Gan To Kagaku Ryoho Año: 2020 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links